Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses

Journal of Immunology

Volumn 160, Issue 11, 1998, Pages 5331-5340

  Homey, Bernhard ^a   Assmann, Till ^a   Vohr, Hans Werner ^c   Ulrich, Peter ^c   Lauerma, Antti I ^b   Ruzicka, Thomas ^a   Lehmann, Percy ^a   Schuppe, Hans Christian ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

^c BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ANIMAL EXPERIMENT; ARTICLE; CONTACT ALLERGY; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INFLAMMATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; CELL MOVEMENT; CYTOKINES; DERMATITIS, CONTACT; EPIDERMIS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-12; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MONOKINES; RNA, MESSENGER; TACROLIMUS; TH1 CELLS; TH2 CELLS; TIME FACTORS;

EID: 0032103937     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Swada, S., G. Suzuki, Y. Kawase, and F. Takaku. 1987. Novel immunosuppressive agent FK506: in vitro effects on the cloned T cell activation. J. Immunol. 139:1797.
2. Sigal, N. H., and F. J. Dumont. 1992. Cyclosporine A, FK506 and rapamycin: pharmacological probes of lymphocyte signal transduction. Annu. Rev. Immunol 10:519.
3. Thomsen. A. W. 1990. FK506 enters the clinic. Immunol. Today 11:35.
4. Mrowietz, U. 1992. The enigma of cyclosporin A treatment for psoriasis: systemic efficacy versus topical non-responsiveness. Acta Dermato-Venereol 72:321.
5. Nakagawa, H., T. Etoh, Y. Ishibashi, Y. Higaki, M. Kawashima, H. Torii, and S. Harada. 1994. Tacrolimus ointment for atopic dermatitis. Lancet 344:883.
6. Aoyama, H., N. Tabata, M. Tanaka, Y. Uesugi, and H. Tagami. 1995. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment. Br. J. Dermatol 133:494.
7. Ruzicka, T., T. Bieber, E. Schöpf, A. Rubins, A. Dobozy, J. D. Bos, S. Jablonska, I. Ahmed, K. Thestrup Pedersen, F. Daniel, A. Finzi, and S. Reitamo. 1997. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N. Engl. J. Med. 337:816.
8. Michel, G., L. Kemeny, B. Homey, and T. Ruzicka. 1996. FK506 in the treatment of inflammatory skin disease: promises and perspectives. Immunol. Today 17:106.
9. The European FK506 Multicentre Psoriasis Study Group. 1996. Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. Arch. Dermatol. 132:419.
10. Lauerma, A. I., H. I. Maibach, H. Granlund, P. Erkko, M. Kartamaa, and S. Stubb. 1992. Inhibition of contact allergy reactions by topical FK506. Lancet 340:556.
11. Schulz, B. S., G. Michel, S. Wagner, R. Süss, A Beetz, R. U. Peter, L. Kemeny, and T. Ruzicka. 1993. Increased expression of epidermal IL-8 receptor in psoriasis: down-regulation by FK506 in vitro. J. Immunol. 151:4399.
12. Lemster, B. H., P. B. Carroll, H. R. Rilo, N. Johnson, A. Nikaein, and A. W. Thomson. 1995. IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy. Clin. Exp. Immunol. 99:148.
13. Lauerma, A. I., B. D. Stein, B. Homey, C. H. Lee, E. Bloom, and H. I. Maibach. 1994. Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig. Arch. Dermatol. Res. 286:337.
14. Lauerma, A. I., B. Stein, H. L. Lee, B. Homey, E. Bloom, and H. I. Maibach. 1993. Topical tacrolimus (FK506): percutaneous absorption and effect on allergic and irritant contact dermatitis. J. Invest. Dermatol. 110:491.
15. Homey, B., H. C. Schuppe, T. Assmann, H. W. Vohr, A. I. Lauerma, T. Ruzicka, and P. Lehmann. 1997. A local lymph node assay to analyse immunosuppressive effects of topically applied drugs. Eur. J. Pharmacol. 325:199.
16. Enk, A. H., and S. I. Katz. 1995. Contact sensitivity as a model for T-cell activation in skin. J. Invest. Dermatol. 105:805.
17. Gad, S. C. 1994. The mouse ear swelling test (MEST) in the 1990s. Toxicology 93:33.
18. Garrigue, J. L., J. F. Nicolas, R. Fraginals, C. Benezra, H. Bour, and D. Schmitt. 1994. Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers. Contact Dermatitis 30:231.
19. Homey, B., H. W. Vohr, H. C. Schuppe, and P. Kind. 1995. UV-dependent local lymph node reactions: photoallergy and phototoxicity testing. Curr. Probl. Dermatol. 22:44.
20. Ulrich, P., B. Homey, and H. W. Vohr. 1998. A modified local lymph node assay for the differentiation of contact photoallergy from phototoxicity by analysis of cytokine expression in skin-draining lymph node cells. Toxicology. In press.
21. Platzer, C., G. Richter, K. Überla, W. Müller, H. Blöcker, T. Diamantstein, and T. Blankenstein. 1992. Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction. Eur. J. Immunol. 22:1179.
22. Überla, K., C. Platzer, T. Diamantstein, and T. Blankenstein. 1991. Generation of competitor DNA fragments for quantitative PCR. PCR Methods Appl. 1:136.
23. Wang, A. M., M. V. Doyle, and D. F. Mark. 1989. Quantitaten of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86:9717.
24. Zheng, X. X., T. B. Strom, and A. W. Steele. 1994. Quantitative comparison of rapamycin and cyclosporine effects on cytokine gene expression studies by reverse transcriptase-competitive polymerase chain reaction. Transplantation 58:87.
25. Gilliland, G., S. Perrin, K. Blanchard, and H. F. Bunn. 1990. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87:2725.
26. Gray, P. W., D. Glaister, E. Chen, D. V. Goeddel and D. Pennica. 1986. Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for murine interleukin Ibeta. J. Immunol. 137:3644.
27. Schoenhaut, D. S., A. O. Chua, A. G. Wolitzky, P. M. Quinn, C. M. Dwyer, M. K. Gately, and U. Gubler. 1992. Cloning and expression of murine IL-12. J. Immunol. 148:3433.
28. Tekamp-Olson, P., C. Gallegos, D. Bauer, J. McClain, B. Sherry, M. Fabre, S. van Denter, and A. Cerami. 1990. Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues. J. Exp. Med. 172:911.
29. Miyatake, S., T. Otsuka, T. Yokuta, F. Lee, and K. Arai. 1985. Structure of the chromosomal gene granulocyte-macrophage colony stimulating factor: comparison of the mouse and human genes. EMBO J. 4:2561.
30. Graham, R. W., T. Atkinson, D. G. Kilburn, R. C. Miller, Jr., and R. A. J. Warren. 1993. Rational design and PCR-based synthesis of an artificial Schizophyllum commune xylanase gene. Nucleic Acids Res. 21:4923.
31. Murray, L. J., R. Lee, and C. Martens. 1990. In vivo cytokine gene expression in T cell subsets of autoimmune MRL/Mp-lpr/lpr mouse. Eur. J. Immunol. 20:163.
32. Sander, B., J. Andersson, and U. Andersson. 1991. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev. 1919:65.
33. Prussin, C., and D. Metcalfe. 1995. Detection of intracytoplasmatic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J. Immunol. Methods 188:117.
34. Van Loveren, H., and P. W. Askenase. 1984. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. J. Immunol. 133:2397.
35. + T cell populations that mediate delayed-type hypersensitivity. J. Immunol. 133:2402.
36. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
37. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of TH1 cells. Immunol. Today 14:335.
38. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
39. McKnight, A. J., G. J. Zimmer, I. Fogelman, S. F. Wolf, and A. K. Abbas. 1994. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:2172.
40. Sypek, J. P., C. L. Chung, S. E. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med 177:1797.
41. Enk, A. H., and S. I. Katz. 1992. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA 89:1398.
42. Bos, J. D., M. L. Kapsenberg, and J. H. Smitt. 1994. Pathogenesis of atopic eczema. Lancet 343:1338.
43. Cooper, K. D. 1994. Atopic dermatitis: recent trends in pathogenesis and therapy. J. Invest. Dermatol. 102:128.
44. Bata Csorgo, Z., C. Hammerberg, J. J. Voorhees, and K. D. Cooper. 1995 Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J. Invest. Dermatol. 105:89S.
45. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz. 1993. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J. immunol. 150:3698.
46. Kupper, T. S., and R. W. Groves. 1995. The interleukin-1 axis and cutaneous inflammation. J. Invest Dermatol. 105:62.
47. Keicho, N., S. Sawada, K. Kitamura, H. Yotsumoto, and F. Takaku. 1991. Effects of an immunosuppressant, FK506, on interleukin 1α production by human macrophages and a macrophage-like cell line, U937. Cell. Immunol. 132:285.
48. Reisman, L., W. G. Lin, and G. P. Martinelli. 1995. Modulation of interleukin-1 secretion by immunosuppressive drugs, alone and in combination. Transplant. Immunol. 3:45.
49. Steinman, R., L. Hoffman, and M. Pope. 1995. Maturation and migration of cutaneous dendritic cells. J. Invest. Dermatol. 105:25.
50. Ozawa, H., S. Nakagawa, H. Tagami, and S. Aiba. 1996. Interleukin-1 beta and granulocyte- macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J. Invest. Dermatol. 106:441.
51. Schröder, J. M. 1995. Cytokine networks in the skin. J. Invest. Dermatol. 105:20S.
52. Müller, G., J. Saloga, T. Germann, G. Schuler, J. Knop, and A. H. Enk. 1995. IL-12 as a mediator and adjuvant for the induction of contact sensitivity in vivo. J. Immunol. 155:4661.
53. Schwarz, A., S. Grabbe, Y. Aragane, K. Sandkuhl, H. Riemann, T. Luger, M. Kubin, G. Trinchieri, and T. Schwarz. 1996. Interleukin-12 prevents ultraviolet B-induced local immunosuppression and overcomes UVB-induced tolerance. J. Invest. Dermatol. 106:1187.
54. Riemann, H., A. Schwarz, S. Grabbe, Y. Aragane, T. A. Luger, M. Wysocka, M. Kubin, G. Trinchieri, and T. Schwarz. 1996. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J. Immunol. 156:1799.
55. Fehr, B. S., A. Takashima, H. Matsue, J. S. Gerometta, P. R. Bergstresser, and P. D. Cruz. 1994. Contact sensitization induces proliferation of heterogeneous populations of hapten-specific T cells. Exp. Dermatol. 3:189.
56. Hope, J. C. R. J. Dearman, I. Kimber, and S. J. Hopkins. 1994. The kinetics of cytokine production by draining lymph node cells following primary exposure of mice to chemical allergens. Immunology 83:250.
57. Schreiber, S. L., and G. R. Crabtree. 1992. The mechanism of action of cyclosporine A and FK506. Immunol. Today 13:136.
58. Rao, A. 1994. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15:274.
59. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz, 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
60. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
61. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
62. Van Seventer, G. A., Y. Shimizu, K. J. Morgan, and S. Shaw. 1990. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144:4579.
63. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607.
64. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Phillips, L. L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
65. Freeman, G. J., F. Borriello, R. J. Hodes, H. Reiser, J. G. Gribben, J. W. Ng, J. Kim, J. M. Goldberg, K. Hathcock, G. Laszlo, L. A. Lombard, S. Wang, G. S. Gray, L. M. Nadler, and A. H. Sharpe. 1993. Murine B7-2, an alternative CTLA-4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178:2185.
66. Panhans, A., and T. Bieber. 1996. FK506 (tacrolimus) impairs the phenotypic and functional differentiation of human epidermal Langcrhans cells. J. Invest. Dermatol. 107:485.
67. Malek, T. R., and J. D. Ashwell. 1985. Interleukin 2 upregulates expression of its receptor on a T cell clone. J. Exp. Med. 161:1575.
68. Paul, W. E., and J. Ohara. 1987. B-cell stimulatory factor-1/interleukin 4. Annu. Rev. Immunol. 5:429.
69. Grewe, M., K. Gyufko, E. Schöpf, and J. Krutmann. 1994. Lesional expression of interteron-gamma in atopic eczema. Lancet 343:25.
70. Grewe, M., S. Walther, K. Gyufko, W. Czech, E. Schöpf, and J. Krutmann. 1995. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J. Invest. Dermatol. 105:407.